Company page
Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc. is a public company traded under the ticker ARQT in the American market. The company has a market capitalization of approximately $3.42 billion. Arcutis focuses on developing innovative therapies for dermatological conditions.
- Ticker
- ARQT:NASDAQ
- Asset type
- Stock
- Market cap
- $2.99B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD